Received May 26, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | UNK | — |
itching; still getting chicken pox like spots; This non-serious case was reported by a consumer and described the occurrence of varicella-like rash in a 59-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Concomitant products included acrivastine (Benadryl). On 29-APR-2025, the patient received Shingrix. On 04-MAY-2025, 5 days after receiving Shingrix, the patient experienced varicella-like rash (Verbatim: still getting chicken pox like spots). On an unknown date, the patient experienced pruritus (Verbatim: itching). The outcome of the varicella-like rash was not resolved and the outcome of the pruritus was not reported. It was unknown if the reporter considered the varicella-like rash and pruritus to be related to Shingrix. It was unknown if the company considered the varicella-like rash and pruritus to be related to Shingrix. Additional Information: GSK Receipt Date: 16-MAY-2025 The patient self-reported this case for herself. The patient reported that she took the Shingrix vaccine and experienced symptoms such as still getting chicken pox like spots and started taking Benadryl to help with itching but spots were ongoing. The symptoms were not treated. No other products were received by the patient.